Massachusetts Town Bans Tobacco Sales to Those Born after 21st Century

Regulations by 2FIRSTS.ai
Mar.12.2024
Massachusetts Town Bans Tobacco Sales to Those Born after 21st Century
Brookline, Massachusetts passes law banning tobacco sales to those born after 21st century, setting model for nationwide crackdown.

According to La Voz, the town of Brookline, Massachusetts in the United States has passed an ordinance that prohibits the sale of tobacco to anyone born after the 21st century. This regulation has become a model for strict crackdowns on tobacco products.

 

This regulation is the first of its kind in the United States, passed in Brookline in 2020. It was recently confirmed by the Supreme Court after a review last week, and may lead other communities to adopt similar bans. Ultimately, over the next few decades, all new generations may be unable to purchase tobacco. The law prohibits individuals born on or after January 1, 2000, from buying tobacco products.

 

Former Republican governor Charlie Baker had previously enacted a law in 2018 that prohibited anyone under the age of 21 from purchasing any tobacco products in the state, including cigarettes, cigars, and e-cigarettes.

 

Supporters of the regulation argue that the state has the authority to take independent action to restrict the sale of harmful products.

 

However, most convenience store owners who rely on tobacco product sales oppose this and believe that this measure conflicts with the state law of 2018. The law allows people aged 21 and over to purchase tobacco products, which could result in distinguishing between two categories of adults: those who can buy cigarettes and those who cannot.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Portugal to Tax Nicotine Pouches from 2026 at €0.065 per Gram
Portugal to Tax Nicotine Pouches from 2026 at €0.065 per Gram
Portugal’s 2026 State Budget adds nicotine pouches to the IEC by inserting Article 104-D into the Excise Code’s tobacco chapter. A specific duty of €0.065/g applies from 2026, with rounding to whole grams. The Budget also defines pouches (natural nicotine, up to 12 mg, tobacco-free, oral mucosal absorption). Lusa projects €1.676B in tobacco excise for 2026; combined levies near €1.993B.
Oct.30 by 2FIRSTS.ai
Leaked EU Paper Suggests COP11 Push to Ban Nicotine Pouches and Flavoured Nicotine Products
Leaked EU Paper Suggests COP11 Push to Ban Nicotine Pouches and Flavoured Nicotine Products
According to media reports, a leaked European Commission document indicates the EU plans to push for its strictest regulatory framework on nicotine and tobacco products at COP11 in Switzerland this November, including measures such as a full ban on nicotine pouches and flavoured products.
Oct.10 by 2FIRSTS.ai
QISI’s Dongguan Factory Posts Recruitment Notice for Production Positions
QISI’s Dongguan Factory Posts Recruitment Notice for Production Positions
QISI’s Dongguan factory has posted new production job openings, following earlier reports of a shutdown at its Zhuhai site.
Oct.15
New Poll Shows 80% of Voters Support Strengthening Enforcement Against Illegal E-Cigarettes, Could Impact Swing Districts
New Poll Shows 80% of Voters Support Strengthening Enforcement Against Illegal E-Cigarettes, Could Impact Swing Districts
A new poll shows 80% of voters support stronger enforcement against illegal e-cigarette production, potentially impacting swing districts.
Oct.17 by 2FIRSTS.ai
South Korea Again Delays Tobacco Business Act Amendment on Synthetic Nicotine
South Korea Again Delays Tobacco Business Act Amendment on Synthetic Nicotine
South Korea’s amendment to the Tobacco Business Act, which would classify synthetic nicotine vapes and vape liquids as “tobacco” for regulatory and taxation purposes, has been delayed once again. Despite the government stressing its urgency due to youth access and risks of illicit drug mixing, both ruling and opposition parties at the Legislation and Judiciary Committee meeting agreed that the bill requires further discussion.
Nov.13 by 2FIRSTS.ai
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai